Literature DB >> 29107108

Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U.

Xueying Yang1, Chi Chiu Wang2, Wayne Yuk Wai Lee3, Jone Trovik4, Tony Kwok Hung Chung5, Joseph Kwong6.   

Abstract

Endometrioid endometrial carcinoma (EEC) is one of the common causes of cancer-related mortality in women. Mounting evidences suggest that long noncoding RNAs (lncRNAs) function in multiple cancers. In this study, we discovered that HAND2-AS1, a lncRNA transcribed antisense adjacent to Heart and Neural Crest Derivatives Expressed 2 (HAND2) in chromosome 4q33-34, is significantly down-regulated in EEC. HAND2-AS1 and HAND2 were frequently down-regulated in EEC tissues, especially in poor differentiated tumor tissues. Down-regulation of HAND2-AS1 and HAND2 was correlated with tumor grade, lymph node metastasis and recurrence of EEC patients. HAND2-AS1 and HAND2 were co-downregulated by promoter DNA hypermethylation in EEC. Overexpression of HAND2-AS1 in EEC cells demonstrated that HAND2-AS1 suppressed migration and invasion of EEC cells. Similarly, overexpression of HAND2 also inhibited migration and invasion EEC cells indicating that HAND2-AS1 and HAND2 had a concordant role in the progression of EEC. However, HAND2 was not regulated by HAND2-AS1 in EEC. Furthermore, the anti-tumorigenic effect of HAND2-AS1 was mediated by down-regulating NMU, which has an oncogenic role in EEC. Our findings therefore provide the first evidence that HAND2-AS1 is a critical tumor suppressor in EEC.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endometrial carcinoma; HAND2; HAND2-AS1; LncRNA; NMU; Promoter hypermethylation

Mesh:

Substances:

Year:  2017        PMID: 29107108     DOI: 10.1016/j.canlet.2017.10.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  41 in total

1.  Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.

Authors:  Qun Zhang; Zhou Ding; Li Wan; Wenyu Tong; Jialei Mao; Li Li; Jing Hu; Mi Yang; Baorui Liu; Xiaoping Qian
Journal:  Cancer Biol Ther       Date:  2019-10-16       Impact factor: 4.742

2.  LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling.

Authors:  Yanying Wang; Pingping Zhu; Jianjun Luo; Jing Wang; Zhiwei Liu; Wei Wu; Ying Du; Buqing Ye; Dongpeng Wang; Lei He; Weizheng Ren; Jianyi Wang; Xianhui Sun; Runsheng Chen; Yong Tian; Zusen Fan
Journal:  EMBO J       Date:  2019-07-23       Impact factor: 11.598

Review 3.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

4.  Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 overexpression inhibits the proliferation of cancer cells by reducing RUNX2 expression in triple-negative breast cancer.

Authors:  Min Wei; Lei Liu; Zhiwei Wang
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

5.  Energy stress-induced lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and inhibits osteosarcoma progression.

Authors:  Yao Kang; Xiaojun Zhu; Yanyang Xu; Qinglian Tang; Zongwen Huang; Zhiqiang Zhao; Jinchang Lu; Guohui Song; Huaiyuan Xu; Chuangzhong Deng; Jin Wang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

6.  Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.

Authors:  Runsheng Zhao; Jing Song; Yiqiang Jin; Yingying Liu
Journal:  J Mol Histol       Date:  2021-08-13       Impact factor: 2.611

7.  Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma.

Authors:  Daheng Yang; Xianwei Zhang; Zheqian Li; Fei Xu; Chenjie Tang; Hongbing Chen
Journal:  PeerJ       Date:  2021-06-01       Impact factor: 2.984

Review 8.  Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis.

Authors:  Wen-Chu Ye; Shi-Feng Huang; Lian-Jie Hou; Hai-Jiao Long; Kai Yin; Ching Yuan Hu; Guo-Jun Zhao
Journal:  Front Cardiovasc Med       Date:  2021-06-10

9.  LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146.

Authors:  Liping Shan; Wei Liu; Yunhong Zhan
Journal:  Cancer Cell Int       Date:  2021-07-08       Impact factor: 5.722

10.  Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.

Authors:  Priyanka Gokulnath; Tiziana de Cristofaro; Ichcha Manipur; Tina Di Palma; Amata Amy Soriano; Mario Rosario Guarracino; Mariastella Zannini
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.